MM
Mitchell Micah Directeur Commercial
Other M
€4,617
▲ Purchases (1 ops.)
Insider track record Executive Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Mitchell Micah, Directeur Commercial. Director active across 1 company, notably MYOMO, INC.. In total, 25 reports have been logged. Breakdown: 1 buy · 7 sells. Total volume traded: €828k. Activity tracked since 9 June 2021. The latest transaction was filed on 14 May 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations 25 total
▼ Chief Commercial Officer · Executives · 14 May 2025 · MYOMO, INC. 90,231 shares @ US$0.861 100.0% of flow Common Stock SEC:0001193125-26-227325
▼ Chief Commercial Officer · Executives · 14 May 2025 · MYOMO, INC. 90,231 shares @ US$0.861 0.20% mcap 48.9% of flow Common Stock SEC:0001193125-26-227325:0
▼ Chief Commercial Officer · Executives · 14 Mar 2025 · MYOMO, INC. 48,000 shares @ US$5.1576 24.4% of flow Common Stock SEC:0000950170-25-043214:0
▼ Chief Commercial Officer · Executives · 14 Mar 2025 · MYOMO, INC. 48,000 shares @ US$5.1576 24.4% of flow Common Stock SEC:0000950170-25-039617:0
◆ Chief Commercial Officer · Executives · 11 Mar 2025 · MYOMO, INC. 3,737 shares 0Common Stock SEC:0000950170-25-039582:0
▼ Chief Commercial Officer · Executives · 14 Mar 2025 · MYOMO, INC. 48,000 shares @ US$5.1576 24.4% of flow Common Stock SEC:0000950170-25-039607:0
◆ Chief Commercial Officer · Executives · 11 Mar 2024 · MYOMO, INC. 3,737 shares 0Common Stock SEC:0000950170-25-038808:0
◇ Chief Commercial Officer · Executives · 9 Jun 2024 · MYOMO, INC. 1,717 shares 0Common Stock SEC:0000950170-25-008883:0
● Chief Commercial Officer · Executives · 1 Jul 2024 · MYOMO, INC. 15,500 shares @ US$3.02 4.7% of flow Common Stock SEC:0000950170-24-080993:0
● Chief Commercial Officer · Executives · 10 Jun 2024 · MYOMO, INC. 6,837 shares @ US$3.377 2.3% of flow Common Stock SEC:0000950170-24-081017:0
● Chief Commercial Officer · Executives · 10 Jun 2024 · MYOMO, INC. 6,837 shares @ US$3.377 2.3% of flow Common Stock SEC:0000950170-24-072449:0
◆ Chief Commercial Officer · Executives · 5 Jun 2024 · MYOMO, INC. 50,000 shares 0Common Stock SEC:0000950170-24-070801:0
● Chief Commercial Officer · Executives · 11 Mar 2024 · MYOMO, INC. 5,359 shares @ US$3.51 1.8% of flow Common Stock SEC:0000950170-24-030820:0
◆ Chief Commerical Officer · Executives · 28 Jun 2023 · MYOMO, INC. 80,000 shares 0Common Stock SEC:0001209191-23-040343:0
◆ Chief Commerical Officer · Executives · 8 Mar 2023 · MYOMO, INC. 17,000 shares 0Common Stock SEC:0001209191-23-017971:0
▲ Chief Commerical Officer · Executives · 17 Jan 2023 · MYOMO, INC. 15,384 shares @ US$0.325 0.5% of flow Common Stock SEC:0001209191-23-003862:0
Ideal exit: 14 Oct 2023 (T+270) ● Chief Commerical Officer · Executives · 13 Jun 2022 · MYOMO, INC. 1,846 shares @ US$1.794 0.0091% mcap 2.2% of flow Common Stock SEC:0001209191-22-037260:0
◆ Chief Commerical Officer · Executives · 8 Jun 2022 · MYOMO, INC. 28,000 shares 0Common Stock SEC:0001209191-22-035965:0
◆ Chief Commerical Officer · Executives · 20 May 2022 · MYOMO, INC. 7,424 shares 0Common Stock SEC:0001209191-22-031714:0
▼ Chief Commerical Officer · Executives · 20 Jul 2021 · MYOMO, INC. 5,745 shares Common Stock SEC:0001209191-21-047782
▼ Chief Commerical Officer · Executives · 20 Jul 2021 · MYOMO, INC. 5,745 shares Common Stock SEC:0001209191-21-047782:0
● Chief Commerical Officer · Executives · 11 Jun 2021 · MYOMO, INC. 2,133 shares Common Stock SEC:0001209191-21-040219:0
● Chief Commerical Officer · Executives · 11 Jun 2021 · MYOMO, INC. 2,133 shares Common Stock SEC:0001209191-21-040219
◆ Chief Commerical Officer · Executives · 9 Jun 2021 · MYOMO, INC. 5,700 shares 0Common Stock SEC:0001209191-21-039874
◆ Chief Commerical Officer · Executives · 9 Jun 2021 · MYOMO, INC. 5,700 shares 0Common Stock SEC:0001209191-21-039874:0
About Mitchell Micah Micah Mitchell is the Chief Commercial Officer at Myomo, Inc., a company developing rehabilitation solutions for patients. In his role, he is responsible for the commercial strategy and growth of the company, ensuring that products meet customer needs while adhering to industry standards.